LCM
Laurion Capital Management Portfolio holdings
AUM
$867M
This Quarter Return
+0.48%
1 Year Return
+5.19%
3 Year Return
+14.26%
5 Year Return
+18.43%
10 Year Return
+26.97%
AUM
$3.56B
AUM Growth
+$3.56B
(-1%)
Cap. Flow
-$94.9M
Cap. Flow
% of AUM
-2.67%
Top 10 Holdings %
Top 10 Hldgs %
57.47%
Holding
332
New
38
Increased
48
Reduced
35
Closed
89
Top Buys
| 1 |
Apple
AAPL
|
$214M |
| 2 |
ATVI
Activision Blizzard Inc.
ATVI
|
$197M |
| 3 |
Amazon
AMZN
|
$184M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$86.6M |
| 5 |
Alibaba
BABA
|
$69M |
Top Sells
| 1 |
Target
TGT
|
$107M |
| 2 |
T-Mobile US
TMUS
|
$104M |
| 3 |
Citigroup
C
|
$98.8M |
| 4 |
JPMorgan Chase
JPM
|
$94.4M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
$92.5M |
Sector Composition
| 1 | Technology | 23.56% |
| 2 | Healthcare | 20.7% |
| 3 | Consumer Discretionary | 19.24% |
| 4 | Communication Services | 17.27% |
| 5 | Utilities | 6.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Schrodinger
SDGR
$1.42B
| $5.59M | 0.03% |
299,049
-325,361
| -52% | -$6.08M |
|
77
Oracle
ORCL
$628B
| $5.16M | 0.02% |
63,176
-297,875
| -83% | -$24.3M |
|
78
Zoom
ZM
$25B
| $5.16M | 0.02% |
+76,144
| New | +$5.16M |
|
79
Rallybio
RLYB
$24.1M
| $5.15M | 0.02% |
783,291
+381,291
| +95% | +$2.51M |
|
80
S&P Global
SPGI
$165B
| $5.14M | 0.02% |
15,352
+9,023
| +143% | +$3.02M |
|
81
Scholar Rock
SRRK
$3.3B
| $5.01M | 0.02% |
553,700
| – | – |
|
82
Solid Biosciences
SLDB
$448M
| $4.99M | 0.02% |
928,169
-228,431
| -20% | +$4.58M |
|
83
Ferguson
FERG
$46.1B
| $4.76M | 0.02% |
37,500
+33,400
| +815% | +$4.24M |
|
84
Fortinet
FTNT
$58.7B
| $4.28M | 0.02% |
87,550
+27,037
| +45% | +$1.32M |
|
85
Pyxis Oncology
PYXS
$91.2M
| $4.25M | 0.02% |
3,170,803
| – | – |
|
86
Blackstone
BX
$131B
| $4.18M | 0.02% |
+56,347
| New | +$4.18M |
|
87
ON Semiconductor
ON
$19.5B
| $4.13M | 0.02% |
+66,168
| New | +$4.13M |
|
|
MBAC.U
88
DELISTED
M3-Brigade Acquisition II Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant
MBAC.U
| $3.94M | 0.02% |
400,000
| – | – |
|
89
Alaunos Therapeutics
TCRT
$4.43M
| $3.71M | 0.02% |
5,720,500
+1,500,000
| +36% | +$974K |
|
90
Biomea Fusion
BMEA
$114M
| $3.62M | 0.02% |
429,400
| – | – |
|
|
VMW
91
DELISTED
VMware, Inc
VMW
| $3.46M | 0.02% |
+28,221
| New | +$3.46M |
|
92
Arrowhead Research
ARWR
$3.84B
| $3.4M | 0.02% |
83,900
-195
| -0.2% | -$7.91K |
|
93
UroGen Pharma
URGN
$896M
| $3.38M | 0.02% |
380,600
| – | – |
|
94
Pfizer
PFE
$141B
| $3.31M | 0.02% |
+64,642
| New | +$3.31M |
|
95
GH Research
GHRS
$870M
| $3.05M | 0.01% |
314,930
| – | – |
|
96
Taysha Gene Therapies
TSHA
$791M
| $2.92M | 0.01% |
1,292,600
+850,000
| +192% | +$1.92M |
|
|
PSTX
97
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $2.89M | 0.01% |
545,700
| – | – |
|
|
AUTL
98
Autolus Therapeutics
AUTL
$383M
| $2.85M | 0.01% |
+1,500,000
| New | +$2.85M |
|
99
Clearfield
CLFD
$437M
| $2.82M | 0.01% |
+30,000
| New | +$2.82M |
|
100
Lineage Cell Therapeutics
LCTX
$281M
| $2.78M | 0.01% |
2,377,940
| – | – |
|